Cell banking produces well-characterised research-grade or clinical-grade master and working cell banks.
Currently Offered
Stemmatters isolates and banks a wide variety of human cells, producing well-characterised research- or clinical-grade master and working cell banks stored as vials or bags in vapour-phase liquid nitrogen or freezers, all within a cGMP contract manufacturing service for advanced therapies.
Quality is validated through cell characterisation and functional assays, ensuring a sustainable supply of qualified starting material. The service specialises in manufacturing advanced therapy medicinal products, including somatic cell therapy medicinal products and tissue-engineered products, with batch release, storage and retrieval under cGMP compliance.
Cell Banking produces characterized cell banks spanning research-grade engineering banks to qualified working banks, a characterized cell bank pipeline.
Cell Banking produces characterized cell banks spanning research-grade engineering banks to qualified working banks, a characterized cell bank pipeline.